0000950170-24-038097.txt : 20240328
0000950170-24-038097.hdr.sgml : 20240328
20240328163143
ACCESSION NUMBER: 0000950170-24-038097
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240326
FILED AS OF DATE: 20240328
DATE AS OF CHANGE: 20240328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wadhane Jitendra
CENTRAL INDEX KEY: 0001941706
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40881
FILM NUMBER: 24799633
MAIL ADDRESS:
STREET 1: 35 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER NAME:
FORMER CONFORMED NAME: Wadhane Jitu
DATE OF NAME CHANGE: 20220808
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pyxis Oncology, Inc.
CENTRAL INDEX KEY: 0001782223
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 831160910
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
BUSINESS PHONE: (617) 221-9059
MAIL ADDRESS:
STREET 1: 321 HARRISON AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02118
4
1
ownership.xml
4
X0508
4
2024-03-26
false
0001782223
Pyxis Oncology, Inc.
PYXS
0001941706
Wadhane Jitendra
C/O PYXIS ONCOLOGY, INC.
321 HARRISON AVENUE, 11TH FL. SUITE 1
BOSTON
MA
02118
false
true
false
false
SVP, Chief Accounting Officer
false
Common Stock
2024-03-26
4
A
false
131484
0
A
398421
D
Represents restricted stock units that vest 25% on the first anniversary of March 26, 2024, and then in 36 substantially-equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
/s/ Jitendra Wadhane
2024-03-28